相关实验视频
Updated: May 1, 2026
08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
8.2K
DNA高甲基化抑制甲状腺过氧化酶的表达,可能是甲状腺癌的有前途的诊断标记物
Lefan Zhu1,2, Ke Jiang3, Jiayong Huang2,4
1Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
概括
在甲状腺癌中,DNA高甲基化通过招募MBD2.2,使甲状腺过氧化酶 (TPO) 沉默. 定量TPO甲基化评估提供了一个有前途的诊断工具,以区分恶性结节和良性结节.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子瘤学分子瘤学
- 甲状腺癌研究研究
背景情况:
- 甲状腺过氧化酶 (TPO) 的表达在甲状腺癌中经常减少,调节机制在很大程度上没有特征.
- 了解TPO基因沉默对于推进甲状腺癌诊断和治疗至关重要.
研究的目的:
- 研究甲状腺癌中TPO沉默的表观遗传调节.
- 评估TPO甲基化在区分甲状腺癌和良性结节的诊断潜力.
主要方法:
- 使用癌症基因组图谱 (TCGA) 数据对DNA甲基化和TPO表达的分析.
- 在临床样本中通过二硫酸盐测序和定量PCR (qPCR) 验证.
- 在甲状腺癌细胞系中的药物诱导脱甲基化研究和涉及MBD2招募的机械研究.
主要成果:
- 在甲状腺癌中观察到TPODNA甲基化和TPO表达之间存在强烈的反相关性.
- 脱甲基化治疗重新激活了TPO表达,证实了DNA过甲基化的作用.
- DNA高甲基化通过MBD2招募抑制TPO转录.
- 热测序测定表明,恶性和良性甲状腺结节之间的TPO甲基化有显著差异,具有很高的诊断准确性.
结论:
- 由MBD2招募介导的DNA高甲基化是甲状腺癌中TPO基因沉默的关键机制.
- 使用热测序测量TPO甲基化的量化为甲状腺癌检测提供了一个有前途的非侵入性诊断策略.
相关概念视频
01:46Epigenetic Regulation
28.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
01:37Epigenetic Regulation
3.5K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.5K
01:20Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
01:25Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
01:27Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28